Iovance Biotherapeutics
Focus: Iovance is a clinical-stage biotechnology company specializing in adoptive cell therapy, focused on developing tumor-infiltrating lymphocyte (TIL) and TCR-T cell therapies for solid tumors and hematologic malignancies. The company operates at mid-cap biotech scale with a geographically concentrated presence in San Carlos, California.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Open Jobs
31+3 this month
Stable — net +3 jobs in 30d
25 added, 22 removed. Backfill posture.
Should You Work at Iovance Biotherapeutics?
AI assessmentIovance offers meaningful upside for cell therapy specialists willing to join a clinical-stage company at inflection point, but careers depend on pipeline execution and near-term commercial milestones.
Why Work Here
- Deep pipeline of 29 active programs spanning multiple oncology indications with Lifileucel (lead program) in Phase 2/3 across melanoma, lung cancer, and cervical cancer, offering exposure to cutting-edge cell therapy development.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Lifileucel
Growing
Growth
Iovance's lead program with Phase 2/3 data across multiple indications; development focus spanning melanoma, endometrial cancer, and other solid tumors.
Lifileucel + Pembrolizumab
Help build intelligence for Iovance Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.